Purpose: Many planning methods for high dose rate (HDR) brachytherapy treatment planning require an iterative approach. A set of computational parameters are hypothesized that will give a dose plan that meets dosimetric criteria. A dose plan is computed using these parameters, and if any dosimetric criteria are not met, the process is iterated until a suitable dose plan is found. In this way, the dose distribution is controlled by abstract parameters. The purpose of this study is to improve HDR brachytherapy planning by developing a new approach that directly optimizes the dose distribution based on dosimetric criteria.
: Clinical workflow for current approach (left) and our approach (right). With current approaches, physicians iterate through dosimetric criteria and parameters. In our approach, iterations are only done using dosimetric criteria.
Although our model can be used for any brachytherapy cancer site where dosimetric criteria is known or 39 desired, for this study we focus on the treatment of prostate cancer. In the following section, we give some 40 background on inverse planning and integer programs. planning is to determine a set of source dwell times that achieves the given dosimetric criteria.
57
In iterative approaches to HDR brachytherapy planning such as in [11] sites such as for prostate cancer, it is natural to utilize models that directly incorporate them.
74
The model and heuristic presented in this study utilize optimization models from mathematical program-75 ming. In the following paragraphs we give a brief overview of these models, and describe how they relate to 76 brachytherapy dose planning.
77
A mixed integer program (MIP) is an optimization model of the form:
Subject to :
where the known parameters c, A, and b are nx1, mxn, and mx1 matrices of real numbers, respectively, and [12], even on a personal computer.
84
Often, the mathematical structure of MIPs makes it difficult to find a provably optimal solution for them Subject to : 
(HR)Maximize
Since dosimetric indices are not constrained, the indicator variables that make up these dosimetric indices In general, a dose plan computed from HR will not satisfy the dosimetric criteria for the OAR in IPIP
154
(i.e. v s > U s ). In IPIP, the value of the indicator variable x si determines if the dose at P si should be less 155 than R s (x si = 0) or M s (x si = 1). Therefore, setting x si to 0 or 1 is equivalent to setting the dose upper 156 limit for P si to R s or M s respectively. In the current solution to HR, all the OAR indicator variables have 157 been set to 1, making the dose upper limit to these dose points M s . The next step of this heuristic is to set 158 all but U s of the OAR indicator variables to 0. Then, v s is guaranteed to be less than U s for these organs.
159
In this heuristic, the U s dose points in G s receiving the most dose retain a dose upper limit of M s .
160
The remaining dose points are restricted to receive less than R s . This can be accomplished by adding the plan will have higher coverage than the IPIP optimal solution because it has fewer constraints. We impose 164 additional constraints on HR so that it will be feasible for IPIP, and these additional constraints will reduce 165 the coverage of the HR dose plan. Further restricting the coldest dose points will impact CTV coverage the 166 least because they must be altered the least to be excluded from the dosimetric index for that organ. After 167 these constraints are added, HR with the additional constraints is resolved as an LP.
168
A common dosimetric criterion is for CTV coverage to be more than a certain percentage of the CTV.
169
This is represented in IPIP by the constraint L 0 ≤ v 0 . This constraint was removed in HR and is not 170 enforced by the additional constraints added later on. As a consequence, meeting lower bound dosimetric 171 index constraints is not guaranteed by this heuristic. However, usually the only dosimetric index with a 172 lower bound constraint is for CTV coverage, and this dosimetric index is maximized the objective of HR.
173
Therefore, if the upper bound constraints are not too stringent, this criterion is likely to be met or come 174 close.
175
Our IPIP heuristic is summarized as follows:
176
(1) Solve HR.
177
(2) For each G s except the CTV, let P si * denote the N s − U s dose points receiving the least dose in G s in 178 the HR dose plan solution.
179
(3) For every P si ∈ P si * add the constraint
180
(4) resolve updated HR to get dose plan.
181
For the sake of brevity, we will not distinguish between IPIP and this heuristic for the remainder of the 182 paper. 
Patient Data Sets
We applied IPIP retrospectively to 20 prostate cancer patient cases. These patients were chosen to have a be much 213 less than 1cm 3 . We interpreted this to mean less than 0. , CTV coverage drops by 5% but with large reduction to OAR exposure. computations grows slowly (i.e. as a polynomial) with respect to the size of the input. As a consequence, 249 the runtime performance of our IPIP heuristic is reliable for a more general audience of patients given that 250 they have a similar number of dose points.
251
For comparison, IPSA computed a dose plan within 5 seconds on average, with a maximum runtime 252 of 9 seconds. However, IPSA would have required further iterations to achieve dosimetric criteria. These 253 additional iterations are not included in the running time results for IPSA.
254
We also conducted side tests to demonstrate cases in which IPIP does not behave as desired. First 255 we showed a set of dosimetric criteria that cannot be met with IPIP by insisting that the V allowance to the rectum and bladder are utilized (i.e. V 
